Intranasal lidocaine sphenopalatine block: a case of unanswered questions versus unquestioned answers

Oscar De Leon-Casasola^{1

2}, Benjamin L Matson^{3

2}, Felipe Juarez²

Affiliations

¹ Anesthesiology and Pain, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
² Anesthesiology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
³ Anesthesiology and Pain, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA Benjamin.Matson@RoswellPark.org.

Comment

Oscar De Leon-Casasola et al. Reg Anesth Pain Med. 2022 Jan.

. 2022 Jan;47(1):74-75.

doi: 10.1136/rapm-2021-102891. Epub 2021 Aug 12.

Oscar De Leon-Casasola^{1

2}, Benjamin L Matson^{3

2}, Felipe Juarez²

¹ Anesthesiology and Pain, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
² Anesthesiology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
³ Anesthesiology and Pain, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA Benjamin.Matson@RoswellPark.org.

No abstract available

Keywords: acute pain; analgesia; autonomic Nerve Block.

Conflict of interest statement

Competing interests: None declared.

Topical intranasal lidocaine is not a sphenopalatine ganglion block.
Narouze S. Narouze S. Reg Anesth Pain Med. 2021 Mar;46(3):276-279. doi: 10.1136/rapm-2020-102173. Epub 2020 Dec 15. Reg Anesth Pain Med. 2021. PMID: 33323391